We are live on ! Find out more
HHMI

Howard Hughes Medical Institute Portfolio holdings

AUM $416M
1-Year Est. Return 13.82%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$209M
AUM Growth
-$220M
Cap. Flow
-$230M
Cap. Flow %
-109.99%
Top 10 Hldgs %
69.75%
Holding
27
New
Increased
Reduced
4
Closed
2

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.09%
2 Technology 11.3%
3 Financials 10.87%
4 Communication Services 5.26%
5 Consumer Staples 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$168B
-50,000
Closed -$3.25M
K
27
DELISTED
Kellanova
K
-53,250
Closed -$2.87M

Similar funds

Howard Hughes Medical Institute's Q2 2019 Portfolio in Review

As of Q2 2019, Howard Hughes Medical Institute held 27 positions worth $209M, down 51% from $429M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Howard Hughes Medical Institute withdrew a net $230M in Q2 2019, closing 2 positions and reducing 4 holdings. Its most notable exit was Gilead Sciences, an estimated $3.25M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 7.2% a quarter earlier, followed by Technology and Financials.

  • Howard Hughes Medical Institute's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $89.3M.
  • Howard Hughes Medical Institute fully exited Gilead Sciences in Q2 2019, selling an estimated $3.25M.
  • Howard Hughes Medical Institute's ten largest holdings make up 70% of its $209M portfolio in Q2 2019.
  • Howard Hughes Medical Institute opened 0 new positions and closed 2 in Q2 2019.
  • Howard Hughes Medical Institute's portfolio value fell 51% quarter-over-quarter to $209M.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2019, filed 9 Aug 2019.